MYGN logo

Myriad Genetics (MYGN) Current Assets

Annual Current Assets

$313.60 M
+$39.00 M+14.20%

01 December 2023

MYGN Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$293.20 M
+$1.60 M+0.55%

01 September 2024

MYGN Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MYGN Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.2%+10.5%
3 y3 years-19.5%-41.2%
5 y5 years-10.0%-11.0%

MYGN Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-35.3%+14.2%-41.2%+12.1%
5 y5 years-35.3%+14.2%-45.6%+12.1%
alltimeall time-35.3%+2189.1%-45.6%+2071.8%

Myriad Genetics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$293.20 M(+0.5%)
June 2024
-
$291.60 M(+0.4%)
Mar 2024
-
$290.30 M(-7.4%)
Dec 2023
$832.90 M(-9.9%)
$313.60 M(+18.2%)
Sept 2023
-
$265.40 M(-9.8%)
June 2023
-
$294.30 M(+12.5%)
Mar 2023
-
$261.60 M(-4.7%)
Dec 2022
$924.10 M(+10.6%)
$274.60 M(-22.1%)
Sept 2022
-
$352.30 M(-4.0%)
June 2022
-
$367.10 M(-14.1%)
Mar 2022
-
$427.40 M(-11.8%)
Dec 2021
$835.90 M(-18.8%)
$484.80 M(-2.8%)
Sept 2021
-
$498.90 M(-7.4%)
June 2021
-
$538.90 M(+63.7%)
Mar 2021
-
$329.20 M(-16.6%)
Dec 2020
$1.03 B(-4.1%)
-
Sept 2020
-
$394.50 M(+18.9%)
June 2020
$1.07 B(-11.6%)
$331.70 M(-6.6%)
Mar 2020
-
$355.20 M(-2.8%)
Dec 2019
-
$365.30 M(+10.9%)
Sept 2019
-
$329.50 M(-5.5%)
June 2019
$1.21 B(+43.2%)
$348.60 M(+1.7%)
Mar 2019
-
$342.90 M(+1.8%)
Dec 2018
-
$336.80 M(-1.5%)
Sept 2018
-
$341.90 M(+4.4%)
June 2018
$847.70 M(-6.6%)
$327.60 M(-1.2%)
Mar 2018
-
$331.50 M(+1.4%)
Dec 2017
-
$327.00 M(+0.4%)
Sept 2017
-
$325.60 M(+7.9%)
June 2017
$907.20 M(+60.3%)
$301.70 M(-13.4%)
Mar 2017
-
$348.30 M(+2.0%)
Dec 2016
-
$341.60 M(+5.8%)
Sept 2016
-
$322.90 M(+2.7%)
June 2016
$566.00 M(+17.3%)
$314.50 M(-15.5%)
Mar 2016
-
$372.40 M(-0.8%)
Dec 2015
-
$375.50 M(+22.2%)
Sept 2015
-
$307.30 M(+8.4%)
June 2015
$482.60 M(-3.7%)
$283.60 M(+0.4%)
Mar 2015
-
$282.42 M(-11.8%)
Dec 2014
-
$320.09 M(-4.6%)
Sept 2014
-
$335.37 M(+4.0%)
June 2014
$501.40 M(+56.8%)
$322.40 M(-4.7%)
Mar 2014
-
$338.16 M(-25.6%)
Dec 2013
-
$454.51 M(-0.9%)
Sept 2013
-
$458.68 M(-5.2%)
June 2013
$319.83 M(+19.3%)
$483.99 M(+8.1%)
Mar 2013
-
$447.70 M(-2.1%)
Dec 2012
-
$457.33 M(+5.1%)
Sept 2012
-
$435.13 M(+3.0%)
June 2012
$268.14 M(+39.2%)
$422.49 M(+0.9%)
Mar 2012
-
$418.67 M(-3.2%)
Dec 2011
-
$432.44 M(+3.3%)
Sept 2011
-
$418.48 M(+0.1%)
June 2011
$192.57 M(+60.6%)
$418.26 M(+0.6%)
Mar 2011
-
$415.61 M(-6.6%)
Dec 2010
-
$444.81 M(-9.6%)
Sept 2010
-
$491.85 M(+3.8%)
June 2010
$119.87 M
$473.98 M(+5.2%)
DateAnnualQuarterly
Mar 2010
-
$450.62 M(+12.4%)
Dec 2009
-
$400.85 M(-2.3%)
Sept 2009
-
$410.35 M(+12.1%)
June 2009
$100.27 M(-17.8%)
$366.12 M(-19.8%)
Mar 2009
-
$456.57 M(+21.1%)
Dec 2008
-
$376.92 M(+3.1%)
Sept 2008
-
$365.55 M(-3.1%)
June 2008
$122.04 M(-0.8%)
$377.30 M(+49.2%)
Mar 2008
-
$252.95 M(+10.2%)
Dec 2007
-
$229.50 M(-1.5%)
Sept 2007
-
$232.90 M(-7.8%)
June 2007
$123.01 M(+405.9%)
$252.53 M(-24.6%)
Mar 2007
-
$334.73 M(+42.8%)
Dec 2006
-
$234.37 M(-1.4%)
Sept 2006
-
$237.80 M(-5.7%)
June 2006
$24.32 M(+3.9%)
$252.29 M(-0.7%)
Mar 2006
-
$254.02 M(-3.0%)
Dec 2005
-
$261.81 M(+105.6%)
Sept 2005
-
$127.36 M(-6.0%)
June 2005
$23.40 M(-54.3%)
$135.56 M(+34.5%)
Mar 2005
-
$100.77 M(-7.7%)
Dec 2004
-
$109.23 M(-5.3%)
Sept 2004
-
$115.38 M(-15.9%)
June 2004
$51.16 M(-36.0%)
$137.19 M(+46.7%)
Mar 2004
-
$93.52 M(+2.6%)
Dec 2003
-
$91.12 M(-7.1%)
Sept 2003
-
$98.12 M(-4.6%)
June 2003
$80.00 M(+11.1%)
$102.82 M(-15.2%)
Mar 2003
-
$121.23 M(-9.3%)
Dec 2002
-
$133.66 M(+84.7%)
Sept 2002
-
$72.37 M(-15.2%)
June 2002
$72.04 M(+106.1%)
$85.35 M(-7.2%)
Mar 2002
-
$91.93 M(-7.9%)
Dec 2001
-
$99.86 M(-5.5%)
Sept 2001
-
$105.63 M(-23.0%)
June 2001
$34.95 M(+70.9%)
$137.20 M(+2.8%)
Mar 2001
-
$133.47 M(+8.7%)
Dec 2000
-
$122.84 M(+35.9%)
Sept 2000
-
$90.37 M(+5.2%)
June 2000
$20.44 M(-48.8%)
$85.93 M(+49.1%)
Mar 2000
-
$57.63 M(+21.6%)
Dec 1999
-
$47.40 M(+49.5%)
Sept 1999
-
$31.70 M(+131.4%)
June 1999
$39.90 M(+11.8%)
$13.70 M(+1.5%)
Mar 1999
-
$13.50 M(-42.8%)
Dec 1998
-
$23.60 M(+34.1%)
Sept 1998
-
$17.60 M(-44.5%)
June 1998
$35.70 M(+29.8%)
$31.70 M(+1.0%)
Mar 1998
-
$31.40 M(-29.8%)
Dec 1997
-
$44.70 M(-13.4%)
Sept 1997
-
$51.60 M(+6.2%)
June 1997
$27.50 M(-5.2%)
$48.60 M(+29.9%)
Mar 1997
-
$37.40 M(-7.4%)
Dec 1996
-
$40.40 M(-22.6%)
Sept 1996
-
$52.20 M(+3.2%)
June 1996
$29.00 M
$50.60 M(-2.5%)
Mar 1996
-
$51.90 M(-22.8%)
Dec 1995
-
$67.20 M

FAQ

  • What is Myriad Genetics annual total current assets?
  • What is the all time high annual current assets for Myriad Genetics?
  • What is Myriad Genetics annual current assets year-on-year change?
  • What is Myriad Genetics quarterly total current assets?
  • What is the all time high quarterly current assets for Myriad Genetics?
  • What is Myriad Genetics quarterly current assets year-on-year change?

What is Myriad Genetics annual total current assets?

The current annual current assets of MYGN is $313.60 M

What is the all time high annual current assets for Myriad Genetics?

Myriad Genetics all-time high annual total current assets is $484.80 M

What is Myriad Genetics annual current assets year-on-year change?

Over the past year, MYGN annual total current assets has changed by +$39.00 M (+14.20%)

What is Myriad Genetics quarterly total current assets?

The current quarterly current assets of MYGN is $293.20 M

What is the all time high quarterly current assets for Myriad Genetics?

Myriad Genetics all-time high quarterly total current assets is $538.90 M

What is Myriad Genetics quarterly current assets year-on-year change?

Over the past year, MYGN quarterly total current assets has changed by +$27.80 M (+10.47%)